V
Versono
Designed around the realities of CTO crossing
About Versono
Versono Medical is developing an intravascular ultrasonic platform with a development focus on predictability in crossing and treating complex peripheral chronic total occlusions.
The platform is based on a proprietary mode of action combining axial and radial ultrasonic energy delivery and is being designed as a foundation for future clinical investigation.
This technology is investigational and has not been approved or cleared by any regulatory authority. Statements describe development focus and design intent only and do not represent clinical performance or outcomes.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Galway, Ireland
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A4 investors entered at this stage
Enterprise Ireland
DHKN
Western Development Commission
Business Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Versono on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Versono on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.